Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM)

Pediatric Rheumatology

Volumn 15, Issue 1, 2017, Pages

  Abdul Aziz, Rabheh ^a,b   Yu, Chack Yung ^a   Adler, Brent ^a   Bout Tabaku, Sharon ^a   Lintner, Katherine E ^a   Moore Clingenpeel, Melissa ^a   Spencer, Charles H ^a  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b CHILDREN S HOSPITAL OF BUFFALO   (United States)

Author keywords

Juvenile dermatomyositis; MRI

Indexed keywords

CREATINE KINASE; FRUCTOSE BISPHOSPHATE ALDOLASE; LACTATE DEHYDROGENASE; ASPARTATE AMINOTRANSFERASE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CREATINE KINASE BLOOD LEVEL; DIFFUSION WEIGHTED IMAGING; DISEASE EXACERBATION; ELECTROMYOGRAM; FEMALE; HUMAN; HUMAN TISSUE; JUVENILE DERMATOMYOSITIS; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MEDICAL DECISION MAKING; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOSITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOLOGICAL PROCEDURES; RASH; RELAPSE; RETROSPECTIVE STUDY; ANGIOSCOPY; BLOOD; COMPLICATION; DERMATOMYOSITIS; DIAGNOSTIC IMAGING; DISEASE COURSE; ELECTROMYOGRAPHY; EXANTHEMA; INFANT; LOWER LIMB; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SKELETAL MUSCLE;

ADOLESCENT; ASPARTATE AMINOTRANSFERASES; CHILD; CHILD, PRESCHOOL; CREATINE KINASE; DERMATOMYOSITIS; DISEASE PROGRESSION; ELECTROMYOGRAPHY; EXANTHEMA; FEMALE; FRUCTOSE-BISPHOSPHATE ALDOLASE; HUMANS; INFANT; L-LACTATE DEHYDROGENASE; LOWER EXTREMITY; MAGNETIC RESONANCE IMAGING; MALE; MICROSCOPIC ANGIOSCOPY; MUSCLE WEAKNESS; MUSCLE, SKELETAL; RETROSPECTIVE STUDIES;

EID: 85018489475     PISSN: None     EISSN: 15460096     Source Type: Journal    
DOI: 10.1186/s12969-017-0154-4     Document Type: Article

References (17)

1. Rider LG, Katz JD, Jones OY. Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum Dis Clin North Am. 2013;39(4):877-904.
2. Brown VE, et al. An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM). Rheumatology (Oxford). 2006;45(8):990-3.
3. Ramanan AV, et al. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids. Arthritis Rheum. 2005;52(11):3570-8.
4. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344-7.
5. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(8):403-7.
6. Constantin T, et al. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis. Autoimmunity. 2006;39(3):223-32.
7. Spencer CH, et al. Course of treated juvenile dermatomyositis. J Pediatr. 1984;105(3):399-408.
8. Huber AM. Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference. Arthritis Care Res. 2012;64(4):546-53.
9. Naim MY, et al. Enzyme elevation in patients with juvenile dermatomyositis and steroid myopathy. J Rheumatol. 2006;33(7):1392-4.
10. Malattia C, et al. Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis. Ann Rheum Dis. 2014;73(6):1083-90.
11. Lintner KE, et al. Gene copy-number variations (CNVs) of complement C4 and C4A deficiency in genetic risk and pathogenesis of juvenile dermatomyositis. Ann Rheum Dis. 2016;75(9):1599-606.
12. Gowdie PJ, et al. Clinical features and disease course of patients with juvenile dermatomyositis. Int J Rheum Dis. 2013;16(5):561-7.
13. Huppertz HI, Kaiser WA. Serial magnetic resonance imaging in juvenile dermatomyositis--delayed normalization. Rheumatol Int. 1994;14(3):127-9.
14. Pitt AM, et al. MRI-guided biopsy in inflammatory myopathy: initial results. Magn Reson Imaging. 1993;11(8):1093-9.
15. Keim DR, Hernandez RJ, Sullivan DB. Serial magnetic resonance imaging in juvenile dermatomyositis. Arthritis Rheum. 1991;34(12):1580-4.
16. Maillard SM, et al. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology (Oxford). 2004;43(5):603-8.
17. Lazarevic D, et al. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis. 2013;72(5):686-93.